Unmasking a sustained negative effect of SGLT2 inhibition on body fluid volume in the rat
Takahiro Masuda(Jichi Medical University), Daisuke Nagata(Jichi Medical University), Akira Ōnishi(Jichi Medical University), Volker Vallon(Unknown), Yuko Watanabe(Jichi Medical University), Minami Watanabe(Jichi Medical University), Ken Ohara(Jichi Medical University), Keiko Fukuda(Jichi Medical University), Toshimi Imai(Jichi Medical University), Shigeaki Muto(Jichi Medical University), Hermann Koepsell(University of Würzburg)
Cited by 61
Related Papers
Glucose transporters in brain in health and disease
|Pflügers Archiv - European Journal of Physiology|2020|520
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
|American Journal of Physiology-Renal Physiology|2013|481
Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5
|Journal of Clinical Investigation|2003|432
Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5
|Journal of Clinical Investigation|2003|404
Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
|American Journal of Physiology-Renal Physiology|2013|308